Flore vs. Viome: An Honest 2026 Comparison
Both Flore and Viome use your microbiome to personalize gut health — but they do it in fundamentally different ways. Here is an honest, side-by-side comparison so you can decide which fits you.
Flore vs. Viome at a glance
| Flore | Viome | |
|---|---|---|
| Personalization model | Manufactured-to-specification — your formula is produced from your data | Catalog matching — an algorithm recommends pre-made products |
| Test method | Shotgun metagenomics (stool DNA) | Metatranscriptomic (RNA) analysis |
| Use your own lab data | Yes — accepts sequencing from any professional lab | No — requires its proprietary test |
| Peer-reviewed RCT | Yes — mSystems (ASM, 2024) | Observational research; no equivalent RCT |
| Licensed-provider platform | Yes — Flore Clinical | No |
| Reformulates on retest | Yes — iterative test → formulate → retest loop | Periodic re-recommendation |
The core difference: manufactured vs. matched
Viome sequences your microbiome and then recommends which products from its existing catalog to buy — the personalization is in the selection. Flore sequences your stool DNA and then manufactures a formula to your specific results — strain selection, ratios, and prebiotic are produced for you. The practical consequence: a catalog can only recommend what's already on the shelf, while a manufactured formula can target the specific organisms that are actually depleted in your gut.
Where Viome is strong
Viome's RNA-based (metatranscriptomic) approach measures microbial activity, not just presence, and the company has published meaningful observational and disease-correlation research. If you want a broad wellness ecosystem spanning supplements and food scoring from a single brand, Viome is a serious, well-funded option.
“But doesn’t DNA sequencing read dead microbes?”
This is the most common critique of DNA-based testing, and it deserves a straight answer. DNA (metagenomics) can detect genetic material from cells that aren’t actively dividing, plus trace dietary DNA — RNA-based methods like Viome’s argue this overstates what’s “alive.” Here’s why that doesn’t undermine Flore in practice:
- Flore matches to outcomes, not raw reads. Strain selection is driven by clinical results across 40,000+ formulations and a peer-reviewed RCT (mSystems 2024) — not by treating every detected sequence as gospel. Abundance thresholds and keystone/pathobiont logic filter the noise.
- It’s a closed loop. Flore manufactures your formula, then retests — so the method is validated empirically by whether your gut actually changes, which sidesteps the dead-vs-alive debate entirely.
- Shotgun metagenomics gives strain-level resolution that 16S and shallower methods can’t — the depth needed to identify the specific organisms you’re missing.
- RNA has its own tradeoffs. Transcriptomic signals are less stable and capture a single activity snapshot that shifts with diet and time of day. Neither method is perfect; both are legitimate science.
The point isn’t that DNA is flawless — it’s that Flore’s formula is built to your data and proven on retest, with the only randomized controlled trial in the category behind the method.
The honest bottom line
If your priority is a probiotic manufactured to your own data, backed by the category's only peer-reviewed randomized controlled trial, that can use sequencing from any lab and be co-managed by a licensed provider — that's Flore. If you prefer an RNA-based wellness suite with food and supplement recommendations from one catalog, Viome fits. Both operate in real science; Flore's differentiator is that the formula itself is built for you, not picked for you.
Frequently asked questions
Is Flore better than Viome?
They solve the problem differently. Flore manufactures a custom formula from your stool-DNA sequencing and is the only company in the category with a peer-reviewed RCT (mSystems, ASM 2024) and a licensed-provider clinical platform. Viome uses RNA analysis to match you to catalog products. For a formula built specifically to your data, Flore is the manufactured-to-specification choice.
Does Viome have a randomized controlled trial?
Viome has published observational studies and RNA-technology validation, but not a randomized controlled trial demonstrating its personalized recommendations outperform a generic comparator. Flore published that RCT in mSystems (American Society for Microbiology) in 2024.
Can I use my existing microbiome test with Flore?
Yes. Flore accepts sequencing data from any professional lab (SunGenomics, ASU, CosmosID and others). Viome requires its own proprietary test.
Doesn’t DNA sequencing detect dead bacteria?
DNA sequencing can detect genetic material from non-dividing cells, which is the main critique of DNA versus RNA methods. In practice it doesn’t weaken Flore’s approach: Flore selects strains based on clinical outcomes from 40,000+ formulations and a peer-reviewed RCT, applies abundance thresholds to filter noise, and validates each formula by retesting your gut over time — so results are grounded in measured change, not raw read counts.